Is West Pharmaceutical Services, Inc. (WST) a Buy, Sell, or Hold?
NYSE : WST
West Pharmaceutical Services, Inc.
$358.72 USD
-$0.52 (-0.14%)
- Volume
- 707.54K
- Average Volume
- 825.95K
- Market Capitalization
- $25.34B
- P/E Ratio
- 47.70
- Dividend Yield
- 0.24%
- Price Target
- $377.50
- Year High
- $367.66
- Year Low
- $221.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.11
- Current Ratio
- $2.71
Company Overview
NYSE
Eric Green
Medical - Instruments & Supplies
Healthcare
WST
10800
US
USD
Liquidity Metrics
0.11
2.71
2.04
0.77
0.11
Sales & Valuation
$3.07B
7.87
8.64
55.33
6.36
Profitability
$6.8
$493.7M
16.85%
21.16%
17.87%
13.21%
P/E Metrics
47.70
2.78
2.78
Analyst Price Target & Rating
$377.50
$447.00
$295.00
3/5
15 Analysts
-4.97%
Financial Health Scores
16.76
6/9
$1.15B
$4.11B
$1.12B
$667.6M
Key Metrics (TTM)
$24.69B
7.67
29.27
2.71
17.87%
15.24%
2.14%
1.84%
$83.93
113 days
Company Executives
| Name | Title |
|---|---|
| Annette F. Favorite | Chief Human Resources Officer & Senior Vice President |
| Shane Campbell | SVP & Chief Proprietary Segment Officer |
| Eric Green | Non-Independent Chair of the Board, President & Chief Executive Officer |
| John Sweeney | Vice President of Investor Relations |
| Norman Finch | Senior VP, General Counsel & Corporate Secretary |
| Robert W. McMahon | Senior Vice President & Chief Financial Officer |
| Rudy Poussot | Senior Vice President of Strategy & Corporate Development |
| Chad R. Winters | Vice President of Finance & Chief Accounting Officer |
| Kathy DePadua | Senior Vice President and Chief Quality & Regulatory Officer |
| Michele Polinsky | Vice President of Global Communications |
| Devesh Mathur | Senior Vice President & Chief Technology Officer |
Poll Results
No votes yet today — be the first to share your view!
About West Pharmaceutical Services, Inc. (NYSE:WST) Stock
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophist ... icated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
West Reports Second-Quarter 2026 Results
2026-07-23 06:00:00
Raising Full-Year Net Sales and EPS guidance EXTON, Pa., July 23, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026.
Andra AP fonden Has $13.79 Million Stake in West Pharmaceutical Services, Inc. $WST
2026-07-22 03:45:54
Andra AP fonden grew its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 723.5% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 55,007 shares of the medical instruments supplier's stock after buying an additional 48,327 shares during the period. Andra AP fonden
West Declares Quarterly Dividend
2026-07-21 16:00:00
EXTON, Pa., July 21, 2026 /PRNewswire/ -- On July 21, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on August 5, 2026 to shareholders of record on July 29, 2026.
WST Likely to Beat Q2 Earnings Estimates: How to Play the Stock?
2026-07-21 12:36:06
WST heads into Q2 earnings with expectations for revenue and EPS growth, backed by demand for biologics and GLP-1 components plus manufacturing gains.
2026-07-21 10:16:12
Besides Wall Street's top-and-bottom-line estimates for West Pharmaceutical (WST), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.
MMSI vs. WST: Which Stock Should Value Investors Buy Now?
2026-07-20 12:41:03
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Merit Medical (MMSI) or West Pharmaceutical Services (WST). But which of these two stocks is more attractive to value investors?
2026-07-16 11:06:37
West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
2026-07-15 13:10:45
West Pharmaceutical Services, Inc. WST is well positioned for growth, backed by strong demand for HVPs, expanding GLP-1 drug programs and regulatory-driven Annex 1 conversions. However, tariff impacts, destocking in generics and execution challenges at constrained European facilities are concerning.
Frequently Asked Questions
-
What is the current West Pharmaceutical Services, Inc. (WST) stock price?
-
West Pharmaceutical Services, Inc.(NYSE:WST) stock price is $358.72 in the last trading session. During the trading session, WST stock reached the peak price of $367.66 while $221.5 was the lowest point it dropped to. The percentage change in WST stock occurred in the recent session was --0.14% while the dollar amount for the price change in WST stock was -$0.52.
-
WST's industry and sector of operation?
-
The NYSE listed WST is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
-
Who are the executives of WST?
-
Annette F. Favorite | Chief Human Resources Officer & Senior Vice President
Shane Campbell | SVP & Chief Proprietary Segment Officer
Eric Green | Non-Independent Chair of the Board, President & Chief Executive Officer
John Sweeney | Vice President of Investor Relations
Norman Finch | Senior VP, General Counsel & Corporate Secretary -
How many employees does WST have?
-
Number of WST employees currently stands at 10800. WST operates from 530 Herman O. West Drive, Exton, PA 19341-0645, US.
-
Link for WST official website?
-
Official Website of WST is: https://www.westpharma.com
-
How do I contact WST?
-
WST could be contacted at phone #610 594 2900 and can also be accessed through its website. WST operates from 530 Herman O. West Drive, Exton, PA 19341-0645, US.
-
How many shares of WST are traded daily?
-
The average number of WST shares traded daily for last 3 months was 825.95K.
-
What is the market cap of WST currently?
-
The market value of WST currently stands at $25.34B with its latest stock price at $358.72